# The negative association between the docosapentaenoic acid intake and the incidence of AMD based on NHANES 2005–2008

**Authors:** Baiwei Xu, Yi Hu, Jie Di, Zhongwei Liu, Ziyan Yu, Lin Han, Yuan Ning

PMC · DOI: 10.3389/fnut.2024.1435775 · Frontiers in Nutrition · 2024-07-25

## TL;DR

This study found that higher intake of docosapentaenoic acid (DPA) is linked to a lower risk of age-related macular degeneration (AMD) in older adults.

## Contribution

The study identifies a negative association between DPA intake and AMD incidence using NHANES data.

## Key findings

- DPA intake was negatively associated with AMD in multivariate logistic models.
- Quantile regression showed a significant negative link in the highest DPA intake quartile.
- Saturated fatty acids showed no significant association with AMD.

## Abstract

Age-related macular degeneration (AMD) is an ophthalmic disease that causes visual impairment and is one of the leading causes of blindness in the elderly. Fatty acids are essential nutrients required by the body and play a cornerstone role in the life activities of the body. Many studies have reported that fatty acids are involved in the development of AMD. To confirm this association, we conducted the present study.

We analyzed the association between all fatty acid intake and AMD using National Health and Nutrition Examination Survey (NHANES) data from 2005–2008. Quantile regression was performed to assess the effect of fatty acids on AMD at different intake levels.

After adjusting for covariates, only saturated fatty acids showed no significant difference between AMD patients and non-AMD patients (23.64 g vs. 26.03 g, p = 0.052). Total fat (70.88 g vs. 78.86 g, p = 0.024), monounsaturated fatty acids (25.87 g vs. 28.95 g, p = 0.019), polyunsaturated fatty acids (15.10 g vs. 17.07 g, p = 0.017) showed significant differences between the two groups. When AMD was considered as an outcome, the association between AMD and docosaentaenoic acid (DPA) was negative in the multivariate logic model (model 1: OR = <0.001, 95% CI = <0.001 ~ 0.734; model 2: OR = <0.001, 95% CI = <0.001 ~ 0.002; model 3: OR = <0.001, 95% CI = <0.001 ~ 0.002). In the quantile regression, DPA was shown to be negatively associated with the presence of AMD only in the fourth quartile in model 2 and model 3 (model 2: OR = <0.001, 95% CI = <0.001 ~ 0.927; model 3: OR = <0.001, 95% CI = <0.001 ~ 0.775).

Therefore, based on above results, we concluded that DPA intake could prevent the development of AMD.

## Linked entities

- **Chemicals:** docosapentaenoic acid (PubChem CID 5497182)
- **Diseases:** age-related macular degeneration (MONDO:0005150), AMD (MONDO:0005150)

## Full-text entities

- **Diseases:** AMD (MESH:D008268), visual impairment (MESH:D014786), ophthalmic disease (MESH:C535922), blindness (MESH:D001766)
- **Chemicals:** DPA (MESH:C026219), fat (MESH:D005223), monounsaturated fatty acids (MESH:D005229), polyunsaturated fatty acids (MESH:D005231), docosaentaenoic acid (-), Fatty acids (MESH:D005227)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11306050/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11306050/full.md

## References

75 references — full list in the complete paper: https://tomesphere.com/paper/PMC11306050/full.md

---
Source: https://tomesphere.com/paper/PMC11306050